Cranston Lynda Sarah 4
4 · DelMar Pharmaceuticals, Inc. · Filed Oct 1, 2018
Insider Transaction Report
Form 4
Cranston Lynda Sarah
Director
Transactions
- Other
Common Stock
2018-09-28$3.20/sh+71$227→ 2,770 total(indirect: Held by J.G. Cranston & Associates, Inc.)
Footnotes (1)
- [F1]The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock.